Investors Aspect Ratio 1200 480

Investors Overview

Corporate Profile

Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.

Latest Events

August 8, 2022 at 9:00 AM EDT

Stock Quote

Symbol :

Stock Chart

Data Provided by Refinitiv. Minimum 15 minutes delayed.